0 Commentaires
0 Parts
33 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 Commentaires 0 Parts 114 Vue 0 Aperçu
-
Paediatric Epilepsy Therapeutics Market Analysis, Size, Share, Segments & Forecast"Executive Summary Paediatric Epilepsy Therapeutics Market Size and Share Forecast Data Bridge Market Research analyses a growth rate in the paediatric epilepsy therapeutics market in the forecast period 2023-2030. The expected CAGR of paediatric epilepsy therapeutics market is tend to be around 5% in the mentioned forecast period. The market was valued at USD 11.45 billion in 2022, and it...0 Commentaires 0 Parts 470 Vue 0 Aperçu
-
RNAi Therapeutics Market Potential, Size, Share, Trends, and Future Outlook"Future of Executive Summary RNAi Therapeutics Market: Size and Share Dynamics The global RNAi therapeutics market size was valued at USD 965.26 million in 2024 and is expected to reach USD 1,966.10 million by 2032, at a CAGR of 9.30% during the forecast period To thrive in this rapidly transforming marketplace, today’s businesses call for innovative and...0 Commentaires 0 Parts 672 Vue 0 Aperçu
-
Breakthroughs in Pediatric RSV Therapeutics: A New Era of Neonatal ProtectionThe landscape of pediatric healthcare is witnessing a significant shift as new preventive measures for Respiratory Syncytial Virus (RSV) take center stage. For decades, RSV has been a leading cause of hospitalization among infants worldwide, often resulting in severe bronchiolitis and pneumonia. However, recent clinical advancements and the introduction of long-acting monoclonal antibodies have...0 Commentaires 0 Parts 930 Vue 0 Aperçu
-
Breakthroughs in Protein Misfolding: How 2026 Therapeutics are Reshaping the Global Neurodegenerative Disease Market Analysis and Patient CareThe dawn of 2026 has ushered in a transformative era for neurology, focusing heavily on the biological markers of cognitive decline. For decades, the medical community struggled to move beyond symptomatic relief for conditions like Alzheimer’s and Parkinson’s. However, recent advancements in monoclonal antibodies have allowed clinicians to target amyloid-beta plaques with...0 Commentaires 0 Parts 826 Vue 0 Aperçu
-
Can RNA Therapeutics Unlock a New Era in Disease Treatment?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...0 Commentaires 0 Parts 281 Vue 0 Aperçu
-
CD47 Targeting Therapeutics Market Forecast and Future OutlookThe CD47 Targeting Therapeutics Market forecast indicates strong growth potential driven by expanding clinical pipelines and rising demand for novel oncology treatments. As cancer incidence continues to increase globally, healthcare systems and pharmaceutical companies are prioritizing innovative therapies that offer improved survival outcomes. CD47-targeting therapeutics are expected to gain...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
CD47 Targeting Therapeutics Market Growth Supported by Expanding Immunotherapy ResearchThe CD47 Targeting Therapeutics Market Growth is strongly supported by the expanding field of cancer immunotherapy. Over the past decade, immunotherapy has transformed oncology treatment by enabling the immune system to identify and attack cancer cells more effectively. CD47-targeting therapies represent a new generation of immunotherapies that aim to overcome one of the major mechanisms used...0 Commentaires 0 Parts 331 Vue 0 Aperçu
-
China Protein Therapeutics Market Analysis by Product Type and ApplicationChina Protein Therapeutics Market Growth Fueled by Rising Chronic Diseases The China Protein Therapeutics Market is gaining momentum as the prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders continues to rise. Protein-based drugs play a critical role in managing these conditions through targeted therapeutic action. Healthcare providers are increasingly...0 Commentaires 0 Parts 630 Vue 0 Aperçu
-
Digital Therapeutics and AI-Driven Tools: The Impact of Specific Technologies on Early Diagnosis in the Autism Spectrum Disorder Market SegmentThe diagnostic landscape within the Autism Spectrum Disorder Market Segment is undergoing a profound transformation, driven by the integration of Specific Technologies like Digital Therapeutics and AI-Driven Tools. Traditional diagnosis often involves lengthy observational assessments, leading to significant delays that hinder early intervention—a...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Energy Based Therapeutics Market: Is 2026 the Year AI-Driven Lasers Replace the Scalpel for Good?As of January 23, 2026, the energy based therapeutics market is identifying as a powerhouse of medical innovation, with its 2026 valuation reaching approximately $7.4 billion to $8.56 billion. The 2026 landscape is defined by a consistent CAGR of 5.2% to 6.2%, fueled by a global surge in "Minimally Invasive" surgical preferences that reduce recovery times from weeks to mere days. This 2026...0 Commentaires 0 Parts 687 Vue 0 Aperçu
-
Economic Milestones: Evaluating the Total Pharyngeal Cancer Market SizeThe global market for throat cancer therapeutics has reached a multi-billion-dollar valuation, reflecting the critical nature of the disease and the high cost of innovation. This valuation is not just a measure of drug sales, but also includes the vast infrastructure of diagnostic labs, specialized infusion centers, and the growing market for supportive care medications. As treatment regimens...0 Commentaires 0 Parts 918 Vue 0 Aperçu
-
Exosome-Based Neurodegenerative Disease Therapeutics Market Growth, In depth Studies with Top Vendors Analysis By FMINEWARK, DE | The Exosome-Based Neurodegenerative Disease Therapeutics Market, valued at USD 25.9 million in 2025, is projected to reach USD 32.8 million in 2026 and expand rapidly to USD 352.5 million by 2036, registering a CAGR of 26.80% during the forecast period. This growth reflects a structural shift in neurology drug development, as traditional small molecules fail to cross the...0 Commentaires 0 Parts 198 Vue 0 Aperçu
-
Febuxostat Market: Trends, Growth Drivers, and Competitive Analysis"Market Trends Shaping Executive Summary Febuxostat Market Size and Share Febuxostat market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.9% in the above mentioned forecast period and is likely to reach the USD 1,662.16 million by 2029. This Febuxostat Market report covers a...0 Commentaires 0 Parts 472 Vue 0 Aperçu
-
Global Multiple Sclerosis Therapeutics Market Set for Robust Growth Amid Rising Neurological Disorder PrevalenceThe global Multiple Sclerosis Therapeutics Market is experiencing notable growth as the prevalence of neurological disorders increases worldwide. Multiple sclerosis (MS) is a chronic autoimmune condition that affects the central nervous system, leading to progressive disability and long-term health complications. Growing awareness of neurological disorders, improved diagnostic technologies, and...0 Commentaires 0 Parts 372 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek